1.
Int J Med Microbiol
; 298(1-2): 161-8, 2008 Jan.
Artículo
en Inglés
| MEDLINE
| ID: mdl-17702653
RESUMEN
Helicobacter pylori infection remains a significant global public health problem. Vaccine development against this infection appears to be feasible but has not yet delivered its promise in clinical trials. Efforts to improve current vaccination strategies would greatly benefit from a better molecular understanding of the mechanism of protection. Here, we review recent developments in this field.